Lung cancer and mesothelioma

Peer review measures

UK guidance on lung cancers

Other sources of information on lung cancers

Information for patients and carers

Reports | Events | Clinical Reference Group

This page provides details of NCIN's work on lung cancer and mesothelioma, and of the Lung Site Specific Clinical Reference Group (SSCRG). This group covers mesothelioma, small cell lung cancer and non-small cell lung cancer.

Reports on lung cancer and mesothelioma

The following NCIN publications focus on lung cancer and mesothelioma:

Events

NCIN has held two workshops aimed at network clinical leads for lung cancer. The presentations given at each workshop can be found below:

11th February, 2011

8th January, 2010

Clinical Reference Group

The Chair of the Lung SSCRG is Dr Mick Peake, Consultant and Senior Lecturer in Respiratory Medicine (Glenfield Hospital); National Clinical Lead, NHS Cancer Improvement; and Clinical Lead, National Cancer Intelligence Network. The full membership of the group can be found below.

The lead cancer registry for Lung cancer is the Thames Cancer Registry (TCR). They support the SSCRG's analytical work programme and lead on requests for data on lung cancer.

Meetings

Lung SSCRG meetings are held jointly with the National Lung Cancer Audit Clinical Reference Group. Future meetings will be held on the following date:

  • 26th March 2012
  • 4th October 2012

To find out more about these meetings please contact the NCIN Co-ordinating Team by emailing Nicky Coombes or calling 020 8282 6247.

Membership

Name Role Affiliation Linked Role
Michael Lind Chair    
Henrik Møller Thames Cancer Registry    
Sharma Riaz Thames Cancer Registry    
Marie Horton Thames Cancer Registry    
Margreet Luchtenborg Thames Cancer Registry    
Jesme Fox Voluntary Sector The Roy Castle Lung Foundation  
Dave Ardron Consumer   NCRI Consumer Liaison Group, Peer Review, NLCA
Allen Gibbs Pathology Royal College of Pathologists  
Sujal Desai Radiology Royal College of Radiologists (Faculty of Radiology) Staging
Jeanette Draffan Nursing Lung Cancer Nurses Forum Co-morbidity
Sion Barnard Surgery Society of Cardiothoracic Surgeons of Great Britain and Northern Ireland  
Richard Page  Surgery Society of Cardiothoracic Surgeons of Great Britain and Northern Ireland  
Andrew Bates Clinical Oncology JCCO / RCR - Clinical Oncology  
Denis Talbot Medical Oncology JCCO / RCR - Medical Oncology  
Robert Milroy Scotland Lung Cancer Clinical Standards Board Co-morbidity, Mesothelioma
Neil McAndrew Wales Welsh Minimum Dataset group; Director for Clinical Effectiveness - Wales  
Paul Beckett   Royal College of Physicians, Lung Cancer Audit Leads National Lung Cancer Audit
David Baldwin   British Thoracic Society National Lung Cancer Audit
Walter Holland   Faculty of Public Health National Lung Cancer Audit
Ian Woolhouse   Royal College of Physicians - Lung Cancer Audit Leads National Lung Cancer Audit
Jonathon Potter   Royal College of Physicians - CEEU National Lung Cancer Audit
Gerard Daly   Northern Ireland - Ulster Thoracic Society; Regional Advisory Committee on cancer; Northern Ireland Cancer Registry National Lung Cancer Audit
Roz Stanley   Information Centre National Lung Cancer Audit
Ian Watson   Royal College of General Practitioners National Lung Cancer Audit
James Entwhistle   Royal College of Radiologists (Faculty of Radiology) National Lung Cancer Audit
Bob Park Cancer Network Director   Peer Review
Marie Tarplee NHS Improvement    
Anna Gavin NCIN    
Di Riley NCIN    
Linda Dutton NCIN    
Nicky Coombes NCIN    
Trish Stokes NCIN - Cancer Outcomes & Services Dataset    
Louise Wilson National Cancer Peer Review